Results 151 to 160 of about 23,209 (275)

Galantamine potentiates the neuroprotective effect of memantine againstNMDA‐induced excitotoxicity [PDF]

, 2013
João Pedro Lopes, Glauco Tarozzo, Angelo Reggiani, Daniele Piomelli, Andrea Cavalli   +4 more
openalex   +1 more source

Chronic treatment with galantamine rescues reversal learning in an attentional set-shifting test after experimental brain trauma

, 2019
Ihuoma Njoku, Hannah L. Radabaugh, Melissa A. Nicholas, Lindsay A. Kutash, Darik A. O’Neil, Ian P. Marshall, Jeffrey P. Cheng, Anthony E. Kline, Corina O. Bondi   +8 more
openalex   +2 more sources

Formulation and Evaluation of Galantamine Gel as Drug Reservoir in Transdermal Patch Delivery System [PDF]

, 2015
Woo Fong Yen, Mahiran Basri, Mansor Bin Ahmad, Maznah Ismail   +3 more
openalex   +1 more source

Double‐Blind Placebo‐Controlled Trial of Galantamine for Methadone‐Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use

, 2019
Kathleen M. Carroll, Elise E. DeVito, Sarah W. Yip, Charla Nich, Mehmet Sofuoglu   +4 more
openalex   +2 more sources

Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells [PDF]

, 2005
Jacques Barik, Federico Dajas‐Bailador, Susan Wonnacott   +2 more
openalex   +1 more source

Semi-preparative isolation and characterization of a principal oxidative degradation product in galantamine hydrobromide by LC-ESI-MSⁿand 2D-NMR [PDF]

, 2013
S.R. Thomas, Saroj Kumar Paul, Ashutosh Agarwal, C. S. Mathela   +3 more
openalex   +1 more source

Development and Validation of a UPLC-ESI-MS Method for Quantitation of the Anti-Alzheimer Drug Galantamine and other Amaryllidaceae Alkaloids in Plants

, 2019
José de Paiva, Ana Claudia Siqueira De Souza, R. de C. A. Pereira, Paulo Riceli Vasconcelos Ribeiro, Guilherme Julião Zocolo, Edy Sousa de Brito, Otília Deusdênia Loiola Pessoa, Kirley Marques Canuto   +7 more
openalex   +1 more source

P3‐390: Disease progression in patients with mild‐to‐moderate Alzheimer's disease treated with galantamine: Results of a two‐year open‐label study [PDF]

, 2012
Maren Gaudig, Ute Richarz, K. Rettig, Miriam Djelani, Barbara Schäuble   +4 more
openalex   +1 more source

FORMULATION DEVELOPMENT AND EVALUATION OF AQUEOUS POLYMER DISPERSIONS (PELLETS) FOR EXTENDED RELEASE DOSAGE FORMS OF GALANTAMINE HYDROBROMIDE

, 2021
Amol Gayke, Karunakar Shukla, Sourabh Jain   +2 more
openalex   +2 more sources

Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptors [PDF]

, 2018
Natalia M. Kowal, Philip K. Ahring, Vivian W. Y. Liao, Dinesh C Indurti, Benjamin S. Harvey, Susan O’Connor, Mary Chebib, Elín Soffia Ólafsdóttir, Thomas Balle   +8 more
openalex   +1 more source